US20040133093A1 - Non-invasive spectrophotometer - Google Patents

Non-invasive spectrophotometer Download PDF

Info

Publication number
US20040133093A1
US20040133093A1 US10/468,279 US46827903A US2004133093A1 US 20040133093 A1 US20040133093 A1 US 20040133093A1 US 46827903 A US46827903 A US 46827903A US 2004133093 A1 US2004133093 A1 US 2004133093A1
Authority
US
United States
Prior art keywords
light
eye
pupil
centre
retina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/468,279
Other versions
US7853315B2 (en
Inventor
Christopher Glynn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20040133093A1 publication Critical patent/US20040133093A1/en
Assigned to H-ICHECK LTD. reassignment H-ICHECK LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GLYNN, CHRISTOPHER
Assigned to GLYNN, CHRISTOPHER reassignment GLYNN, CHRISTOPHER ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: H-ICHECK LIMITED
Application granted granted Critical
Publication of US7853315B2 publication Critical patent/US7853315B2/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/113Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining or recording eye movement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Definitions

  • the present invention relates to a device for use in non-invasive monitoring of a human or animal subject's bodily functions in vivo.
  • the device relates, more particularly, to such monitoring that uses light beams directed at, and reflected from, various parts of the subject's eye(s) to provide analysable data.
  • a third aim of the present invention is to allow measurement of the amount of light illuminating the eye by focussing the light in Maxwellian view.
  • the present invention provides a device for use in non-invasive monitoring of a human or animal subject's bodily functions in vivo, comprising:
  • a first optical system for identifying the centre of a pupil of an eye of the subject, said first system comprising a first light source for directing light towards the eye, first receiving means for receiving light reflected from the iris of the eye, and first processing means for determining the position of the centre of the pupil from the light reflected from the iris;
  • a second optical system comprising a second light source directing light to a focussing means for focussing light in the plane of the pupil and for directing the focussed light onto the structures within the eye, a second receiving means for receiving light structures from the structure and back through the pupil, and second processing means for analysing the light reflected from the structure;
  • the device therefore comprises at least three major components.
  • the first major component the first optical system is preferably provided by modifying a standard pupillometer, such as that described in U.S. Pat. No. 5,784,145. Further, the general principles of using pupillometry in this context are described in the applicant's previous International Patent Application No. WO/90/12534.
  • the second major component that is the second optical system
  • the second major component is usually provided by modifying a standard spectrophotometer and the general principles of using such spectrophotometric techniques are again described in the applicant's prior International Patent Application No. WO/90/12534.
  • a typical example of the type of structure within the eye onto which light is focussed is the retina.
  • the eye In the spectroscopy field, the eye is in effect the curvette of the body, since it is the only part of the body that is designed to transmit light. Thus, measurement of the characteristics of light reflected from the eye can give an indication of characteristics of bodily functions in general.
  • the third major component that is the alignment means
  • the alignment means is controllable either directly by, or independently of, the subject, for example by use of manually operated lever(s), button(s), joystick(s) and/or one or more computer mice.
  • the alignment means provides' a variable focus capability to the system and may optionally operate in an automatic way without personal intervention from either the subject or the clinician. Indeed, activation of such alignment may also be automatically initiated by the first optical system, once the centre of the pupil in Maxwellian view has been determined.
  • the device is arranged to project an image processed by the first processing means onto the retina of the operator (whether the subject or not), so as to allow the operator to be able to perceive when the position of the centre of the pupil has been determined and so be able to operate the alignment means appropriately.
  • the device may be arranged to gather data from either a selected eye or from both eyes of the subject, that is, to be a monocular or binocular system.
  • the first light source emits infra-red light, for example from one or more LED(s).
  • the second receiving means comprises one or more crystal charged device (ccd)-type camera(s).
  • ccd crystal charged device
  • the first optical system is adapted to monitor, in particular, the location of the edge(s) of the pupil(s), so as to allow calculation of the centre of the pupil(s) by the first processing means.
  • the first and second light sources comprise one or more optical fibre(s) for transmitting light towards the eye(s).
  • the optical fibre(s) are arranged to function as both the light input means and the light receiving means.
  • the second light source and the second receivina means are arranged to monitor the intensity of light of a selected wavelength returning from the retina(s) of the eye(s).
  • the second light source and second receiving means are arranged to monitor the intensity of light of different wavelengths returning from the retina(s) of the eye(s), thereby enabling an absorbance/reflectance characteristic of the retina(s) to be determined.
  • the first and second optical systems may have parts in common.
  • the first and second receiving means can optionally be provided by the same unit.
  • the first and second processing means can also be the same processing means, if desired.
  • human and bodily functions used herein is intended to include the wide variety of different functions that a medical or veterinary practitioner may wish to non-invasively monitor or measure. In particular, it is intended to include the monitoring of any substances and changes in the blood of the retina and any biochemical (organic or inorganic) changes in the cells of the retina of the subject. In addition, any or all of these changes can be monitored in conjunction with changes in the electrical, biochemical or pathological activity of the retina or of the brain.
  • light used herein is, unless otherwise specified, intended to include visible wavelengths and non-visible wavelengths such as infra-red and ultra-violet light, that are non-injurious to the eye and the structures contained within the eye.
  • FIG. 1 shows a schematic representation of the first optical system of an embodiment of the present invention
  • FIG. 2 illustrates an image of the eye on a computer screen, as may be used in one embodiment of the present invention.
  • FIG. 3 shows a schematic representation of the second optical system of an embodiment of the present invention.
  • a first optical system is shown that is capable of identifying the centre 1 of a pupil of an eye of a subject.
  • This first system comprises a first light source 2 that directs light of an infra-red wavelength towards the eye, a first receiving means (not shown) that receives fight subsequently reflected 3 from the iris 4 of the eye, and a first processing means (not shown) that then determines the position of the centre 1 of the pupil from the light 3 so reflected from the iris 4 .
  • Input light 5 is directed by one or a bundle of optical fibre(s) that constitute the first light source 2 and is emitted towards the eye.
  • the device is enclosed in a housing 12 and, depending upon alignment of this housing 12 , the focussed light either passes through the pupil or alternatively is reflected by the iris 4 .
  • the latter light 11 is directed back into the housing 12 of the device and passes as a beam 3 of reflected light that can be detected by the first receiving means.
  • Also shown in FIG. 1 are the anterior chamber 8 of the eye and the lens 9 of the eye.
  • FIG. 2 a Maxwellian view of the eye is shown on a computer screen 6 , the view being a cross-sectional view of the eye about line A-A′ in FIGS. 1 and 3.
  • The, iris 4 is illustrated surrounding the centre 1 of the pupil 13 .
  • a computer-processing unit 20 represents the first and second processing means and the first and second optical systems are depicted as unit 19 .
  • the first optical system is sequentially alignable with respect to the eye such that the first light source 2 directs infra red light either through the pupil 13 or onto the iris 4 .
  • Reflected light 11 from the iris forms a beam 3 that is analysed by the first processing means, so that the centre 1 of the pupil 13 can be determined.
  • the pixels of the image produced by the beam 3 are analysed to determine the location of the circumference of the circle represented by the edge of the iris 4 .
  • the radius of the circle is then calculated by the first processing means, so that the location of the centre 1 can be identified, however other methods of similar calculation are clearly possible.
  • a second optical system comprises a second light source 14 directing light to a focussing means 15 for focussing light in the plane of the pupil 13 and for directing the focussed light onto the retina 10 of the eye.
  • a second receiving means receives light 17 reflected from the retina 10 and back 16 through the pupil 13 .
  • a second receiving and processing means is provided for analysing the light 17 that is reflected from the retina 10 and back through the pupil 13 into the housing 12 of the device.
  • the alignment means (not shown) of the device can be used to align the second optical light so that light is shone through the centre 1 of the pupil 13 in the plane of the pupil 13 , that is in a Maxwellian view.
  • the alignment process can be effected by way of, for example, a joystick ( 18 ) (see FIG. 2), which can be operated by the physician, or the subject themselves. In this way, the operator can view an image of the eye being investigated on a screen 6 and, in conjunction, use the joystick 18 to align the second optical system with the centre 1 of the pupil 13 .
  • the device may be arranged for example such that the first optical system operates automatically (i.e. without manual operation).
  • the first optical system may directly activate the alignment means to position the second optical system into the correct alignment with the centre of the pupil, so as to provide a Maxwelllan view of the eye.
  • input light 14 is directed via an optical fibre from which it is emitted so as to pass through a focussing means 15 and out of the housing 12 of the device towards the centre 1 of the pupil 13 .
  • Light 16 which is reflected back from the retina 10 and back through the pupil 13 , subsequently passes back into the device and travels as a beam 17 along one or more optical fibres to the second processing means.
  • the second processing means analyses the beam 17 to determine the absorbance/reflectance spectrum of the retinal blood supply. Any combination of mono-chromatic lights or white light, as well as wavelengths in the infra-red or ultra-violet spectra can be used. Specific, selected wavelengths permit optimal discrimination of the various blood components, as well as optimal discrimination of the various retinal biochemical functions and components.
  • the system described above can be used for a wide range of applications. For example, it is possible to measure any, or all, of the constituents of the blood of a subject, in vivo. Additionally, when appropriate wavelengths are used, it is also possible to measure the constituents of the cells of the retina or to measure physiological and or pathological changes in the cells of the retina. It is possible to measure the biochemical activity of these cells, in real time.
  • a monocular system can be used as part of a cash-dispensing machine, in which the identity of the person wishing to withdraw cash is checked via non-invasive DNA analysis of the retinal cells.
  • the system is also more suitable for monitoring the blood glucose levels of diabetic patients than conventional needle-based methods, since it is non-invasive.
  • the system in effect provides the subject with the resources of a non-invasive, real time biochemical and haematological laboratory.
  • the system can measure visual evoked potentials more accurately than conventional means, because it is possible to give an accurate amount of light and so the amplitude of response can also be assessed. Conventionally, by contrast, only latency of response is measured. Thus, the present system allows for the assessment of any electrical activity of the retina, so that the activity of the visual areas of the brain can be assessed.
  • the measurements made possible with the present system can be of static samples or of continuous samples in real time.
  • the present invention provides a simple, yet effective way of ensuring that spectrophotometric analysis of a subject can be effected by aligning the light used so that it passes through the centre of the pupil(s) of the subject's eye(s) to provide a Maxwellian view. This ensures that the spectrophotometric measurements made can be accurate and that potential injury, that could otherwise ensue, to the subject's iris(es) and other eye structures is avoided.

Abstract

A device for use in non-invasive monitoring of a human or animal subject's bodily functions in vivo, comprises: (a) a first optical system for identifying the centre (1) of a pupil (13) of an eye of the subject, said first system comprising a first light source (2) for directing light towards the eye, first receiving means for receiving light reflected from the iris (4) of the eye, and first processing means for determining the position of the centre (1) of the pupil (13) from the light reflected (3) from the iris; (b) a second optical system comprising a second light source (14) directing light to a focussing means (15) for focussing light in the plane of the pupil (13) and for directing the focussed light onto the retina (10) of the eye, a second receiving means for receiving light reflected (17) from the retina and back through the pupil (13), and second processing means for analysing the light reflected from the retina (10); and (c) alignment means for aligning the second system with the centre (1) of the pupil (13) as determined by the first system.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a device for use in non-invasive monitoring of a human or animal subject's bodily functions in vivo. The device relates, more particularly, to such monitoring that uses light beams directed at, and reflected from, various parts of the subject's eye(s) to provide analysable data. [0001]
  • Monitoring the functions of a human or animal body is necessary in many different situations. In the past, blood sample gave been taken from the patient or animal and constituents have been measured by spectrophotometry. It is also known to relatively invasively measure the constituents in the blood of the patient or of the animal by bringing the spectrophotometer into contact with the patient or the animal, by for example using modified contact lens systems. The eye, which is the only part of the body that is designed to transmit light, thus acts as the curvette for the spectrophotometer. [0002]
  • BACKGROUND ART
  • The use of spectrophotometric techniques for monitoring the level and variation of one or more parameters indicative of body condition is well known. Thus, U.S. Pat. Nos. 4,157,708 and 4,402,325 disclose ophthalmic devices incorporating one or more plethysmograph assemblies, but these devices have the disadvantage that light is assumed to be introduced along the axis of the pupil of the subject's eye. [0003]
  • In addition, U.S. Pat. Nos. 5,553,617 and 5,919,132 describe further non-invasive methods of measuring body conditions but, again, light introduced into the eye is assumed to be directed along the axis of the pupil. [0004]
  • SUMMARY OF THE INVENTION
  • It is therefore a first aim of the present invention to overcome the disadvantages of the prior art by providing a non-invasive spectrophotomeric system, which ensures that light, used to monitor the body condition of a subject, is directed along the axis of the eye by being focussed in the centre of the plane of the iris, which is otherwise known as being the Maxwellian view of the pupil. [0005]
  • It is a second aim of the present invention to provide such a system that minimises the potential injury to the iris and other structures of the eye, should light (used for spectrophotometric analysis) not be directed through the pupil in Maxwellian view, thus overcoming another disadvantage of the prior art. [0006]
  • A third aim of the present invention is to allow measurement of the amount of light illuminating the eye by focussing the light in Maxwellian view. [0007]
  • Thus, in a first aspect, the present invention provides a device for use in non-invasive monitoring of a human or animal subject's bodily functions in vivo, comprising: [0008]
  • (a) a first optical system for identifying the centre of a pupil of an eye of the subject, said first system comprising a first light source for directing light towards the eye, first receiving means for receiving light reflected from the iris of the eye, and first processing means for determining the position of the centre of the pupil from the light reflected from the iris; [0009]
  • (b) a second optical system comprising a second light source directing light to a focussing means for focussing light in the plane of the pupil and for directing the focussed light onto the structures within the eye, a second receiving means for receiving light structures from the structure and back through the pupil, and second processing means for analysing the light reflected from the structure; and [0010]
  • (c) alignment means for aligning the second system with the centre of the pupil as determined by the first system. [0011]
  • The device therefore comprises at least three major components. [0012]
  • The first major component the first optical system, is preferably provided by modifying a standard pupillometer, such as that described in U.S. Pat. No. 5,784,145. Further, the general principles of using pupillometry in this context are described in the applicant's previous International Patent Application No. WO/90/12534. [0013]
  • The second major component, that is the second optical system, is usually provided by modifying a standard spectrophotometer and the general principles of using such spectrophotometric techniques are again described in the applicant's prior International Patent Application No. WO/90/12534. A typical example of the type of structure within the eye onto which light is focussed is the retina. In the spectroscopy field, the eye is in effect the curvette of the body, since it is the only part of the body that is designed to transmit light. Thus, measurement of the characteristics of light reflected from the eye can give an indication of characteristics of bodily functions in general. [0014]
  • Typically, the third major component, that is the alignment means, is controllable either directly by, or independently of, the subject, for example by use of manually operated lever(s), button(s), joystick(s) and/or one or more computer mice. The alignment means provides' a variable focus capability to the system and may optionally operate in an automatic way without personal intervention from either the subject or the clinician. Indeed, activation of such alignment may also be automatically initiated by the first optical system, once the centre of the pupil in Maxwellian view has been determined. [0015]
  • In one embodiment, the device is arranged to project an image processed by the first processing means onto the retina of the operator (whether the subject or not), so as to allow the operator to be able to perceive when the position of the centre of the pupil has been determined and so be able to operate the alignment means appropriately. [0016]
  • In addition, the device may be arranged to gather data from either a selected eye or from both eyes of the subject, that is, to be a monocular or binocular system. [0017]
  • Typically, the first light source emits infra-red light, for example from one or more LED(s). [0018]
  • Preferably, the second receiving means comprises one or more crystal charged device (ccd)-type camera(s). [0019]
  • In one embodiment, the first optical system is adapted to monitor, in particular, the location of the edge(s) of the pupil(s), so as to allow calculation of the centre of the pupil(s) by the first processing means. [0020]
  • Preferably, the first and second light sources comprise one or more optical fibre(s) for transmitting light towards the eye(s). In a particularly preferred arrangement, the optical fibre(s) are arranged to function as both the light input means and the light receiving means. [0021]
  • In one embodiment the second light source and the second receivina means are arranged to monitor the intensity of light of a selected wavelength returning from the retina(s) of the eye(s). [0022]
  • In an alternative embodiment, the second light source and second receiving means are arranged to monitor the intensity of light of different wavelengths returning from the retina(s) of the eye(s), thereby enabling an absorbance/reflectance characteristic of the retina(s) to be determined. [0023]
  • The first and second optical systems may have parts in common. Thus, for example, the first and second receiving means can optionally be provided by the same unit. Likewise, the first and second processing means can also be the same processing means, if desired. [0024]
  • The expression “human and bodily functions” used herein is intended to include the wide variety of different functions that a medical or veterinary practitioner may wish to non-invasively monitor or measure. In particular, it is intended to include the monitoring of any substances and changes in the blood of the retina and any biochemical (organic or inorganic) changes in the cells of the retina of the subject. In addition, any or all of these changes can be monitored in conjunction with changes in the electrical, biochemical or pathological activity of the retina or of the brain. [0025]
  • The term ‘light’ used herein is, unless otherwise specified, intended to include visible wavelengths and non-visible wavelengths such as infra-red and ultra-violet light, that are non-injurious to the eye and the structures contained within the eye. [0026]
  • The present invention will now be described in further detail by way of the following non-limiting examples with reference to the drawings, in which:[0027]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a schematic representation of the first optical system of an embodiment of the present invention; [0028]
  • FIG. 2 illustrates an image of the eye on a computer screen, as may be used in one embodiment of the present invention; and [0029]
  • FIG. 3 shows a schematic representation of the second optical system of an embodiment of the present invention. [0030]
  • BEST MODE
  • In FIG. 1, a first optical system is shown that is capable of identifying the [0031] centre 1 of a pupil of an eye of a subject. This first system comprises a first light source 2 that directs light of an infra-red wavelength towards the eye, a first receiving means (not shown) that receives fight subsequently reflected 3 from the iris 4 of the eye, and a first processing means (not shown) that then determines the position of the centre 1 of the pupil from the light 3 so reflected from the iris 4.
  • Input light [0032] 5 is directed by one or a bundle of optical fibre(s) that constitute the first light source 2 and is emitted towards the eye. The device is enclosed in a housing 12 and, depending upon alignment of this housing 12, the focussed light either passes through the pupil or alternatively is reflected by the iris 4. The latter light 11 is directed back into the housing 12 of the device and passes as a beam 3 of reflected light that can be detected by the first receiving means. Also shown in FIG. 1 are the anterior chamber 8 of the eye and the lens 9 of the eye.
  • In FIG. 2, a Maxwellian view of the eye is shown on a [0033] computer screen 6, the view being a cross-sectional view of the eye about line A-A′ in FIGS. 1 and 3. The, iris 4 is illustrated surrounding the centre 1 of the pupil 13. A computer-processing unit 20 represents the first and second processing means and the first and second optical systems are depicted as unit 19.
  • The first optical system is sequentially alignable with respect to the eye such that the first [0034] light source 2 directs infra red light either through the pupil 13 or onto the iris 4. Reflected light 11 from the iris forms a beam 3 that is analysed by the first processing means, so that the centre 1 of the pupil 13 can be determined. Typically, the pixels of the image produced by the beam 3 are analysed to determine the location of the circumference of the circle represented by the edge of the iris 4. In one option, the radius of the circle is then calculated by the first processing means, so that the location of the centre 1 can be identified, however other methods of similar calculation are clearly possible.
  • In FIG. 3, a second optical system is shown that comprises a second [0035] light source 14 directing light to a focussing means 15 for focussing light in the plane of the pupil 13 and for directing the focussed light onto the retina 10 of the eye. A second receiving means (not shown) receives light 17 reflected from the retina 10 and back 16 through the pupil 13. A second receiving and processing means (not shown) is provided for analysing the light 17 that is reflected from the retina 10 and back through the pupil 13 into the housing 12 of the device.
  • Once the first optical system has been used to locate the [0036] centre 1 of the pupil 13, the alignment means (not shown) of the device can be used to align the second optical light so that light is shone through the centre 1 of the pupil 13 in the plane of the pupil 13, that is in a Maxwellian view. The alignment process can be effected by way of, for example, a joystick (18) (see FIG. 2), which can be operated by the physician, or the subject themselves. In this way, the operator can view an image of the eye being investigated on a screen 6 and, in conjunction, use the joystick 18 to align the second optical system with the centre 1 of the pupil 13.
  • However, the device may be arranged for example such that the first optical system operates automatically (i.e. without manual operation). Thus, the first optical system may directly activate the alignment means to position the second optical system into the correct alignment with the centre of the pupil, so as to provide a Maxwelllan view of the eye. [0037]
  • Further, instead of the operator viewing the image of the eye on a screen, such an image may be transferred directly onto the retina of the operator, for example by way of the second optical system itself. [0038]
  • As shown in FIG. 3, [0039] input light 14 is directed via an optical fibre from which it is emitted so as to pass through a focussing means 15 and out of the housing 12 of the device towards the centre 1 of the pupil 13. Light 16, which is reflected back from the retina 10 and back through the pupil 13, subsequently passes back into the device and travels as a beam 17 along one or more optical fibres to the second processing means.
  • The second processing means analyses the [0040] beam 17 to determine the absorbance/reflectance spectrum of the retinal blood supply. Any combination of mono-chromatic lights or white light, as well as wavelengths in the infra-red or ultra-violet spectra can be used. Specific, selected wavelengths permit optimal discrimination of the various blood components, as well as optimal discrimination of the various retinal biochemical functions and components.
  • In this way, it is, for example, possible to provide an accurate measurement of the oxygen saturation of the retinal blood flow and, since this is more proximal to blood flow in the toe, finger or ear (as measured by well known prior techniques), it can provide the clinician with a more accurate assessment of the oxygen content of blood delivered to the brain. [0041]
  • The system described above can be used for a wide range of applications. For example, it is possible to measure any, or all, of the constituents of the blood of a subject, in vivo. Additionally, when appropriate wavelengths are used, it is also possible to measure the constituents of the cells of the retina or to measure physiological and or pathological changes in the cells of the retina. It is possible to measure the biochemical activity of these cells, in real time. [0042]
  • Further, it is possible also to use the system to measure the unique DNA profile of any individual and thus provide security checks. For example, a monocular system can be used as part of a cash-dispensing machine, in which the identity of the person wishing to withdraw cash is checked via non-invasive DNA analysis of the retinal cells. [0043]
  • Whereas police currently use breathylisers to check a driver's blood alcohol levels at the road side, using the present system would not only allow such analysis to be more accurately performed, but would also allow analysis of any number of other drugs that can be detrimental to driving, which may also be present in a driver's blood. [0044]
  • Moreover, the system is also more suitable for monitoring the blood glucose levels of diabetic patients than conventional needle-based methods, since it is non-invasive. [0045]
  • It is also possible to measure changes in the arteries and veins of the retina, which may be an indication of generalised arterial and venous disease. Thus, in diabetic patients, who typically can suffer from such generalised arterial disease, it would be possible to non-invasively chart the progression of the disease. [0046]
  • Hence, in general, the system in effect provides the subject with the resources of a non-invasive, real time biochemical and haematological laboratory. [0047]
  • The system can measure visual evoked potentials more accurately than conventional means, because it is possible to give an accurate amount of light and so the amplitude of response can also be assessed. Conventionally, by contrast, only latency of response is measured. Thus, the present system allows for the assessment of any electrical activity of the retina, so that the activity of the visual areas of the brain can be assessed. [0048]
  • The measurements made possible with the present system can be of static samples or of continuous samples in real time. [0049]
  • Thus, the present invention provides a simple, yet effective way of ensuring that spectrophotometric analysis of a subject can be effected by aligning the light used so that it passes through the centre of the pupil(s) of the subject's eye(s) to provide a Maxwellian view. This ensures that the spectrophotometric measurements made can be accurate and that potential injury, that could otherwise ensue, to the subject's iris(es) and other eye structures is avoided. [0050]

Claims (16)

1 A device for use in non-invasive monitoring of a human or animal subject's bodily functions in vivo, comprising:
(a) a first optical system for identifying the centre of a pupil of an eye of the subject, said first system comprising a first light source for directing light towards the eye, first receiving means for receiving light reflected from the iris of the eye, and first processing means for determining the position of the centre of the pupil from the light reflected from the iris;
(b) a second optical system comprising a second light source directing light to a focussing means for focussing light in the plane of the pupil and for directing the focussed light onto the structures within the eye, a second receiving means for receiving light reflected from the structures and back through the pupil, and second processing means for analysing the light reflected from the structures; and
(c) alignment means for aligning the second system with the centre of the pupil as determined by the first system.
2. A device as claimed in claim 1, wherein the alignment means is controllable either directly by, or independently of, the subject.
3. A device as claimed in either claim 1 or claim 2, wherein the alignment means is controllable by use of manually operated lever(s), button(s), joystick(s) and/or one or more computer mice.
4. A device as claimed in any preceding claim, wherein the first and second receiving means are provided by a single receiving means.
5. A device as claimed in any preceding claim, wherein the first and second processing means are provided by a single processing means.
6. A device as claimed in any preceding claim, wherein the device is arranged to project an image processed by the first processing means onto the retina of the operator (whether the subject or not), so as to allow the operator to be able to perceive when the position of the centre of the pupil has been determined and so be able to operate the alignment means appropriately.
7. A device as claimed in any preceding claim, wherein the device is arranged to gather data from either a selected eye or from both eyes of the subject.
8. A device as claimed in any preceding claim, wherein the first light source emits infra red light.
9. A device as claimed in any preceding claim, wherein the first light source comprises one or more LED(s).
10. A device as claimed in any preceding claim, wherein the first or second receiving means comprises one or more ccd camera(s).
11. A device as claimed in any preceding claim, wherein he first optical system is adapted to monitor the location of the edge(s) of the pupil(s) so as to allow calculation of the centre of the pupil(s) by the first processing means.
12. A device as claimed in any preceding claim, wherein the first and second light sources comprise one or more optical fibre(s) for transmitting light towards the eye(s).
13. A device as claimed in claim 12, wherein the optical fibre(s) are arranged to function both as light input means and light receiving means.
14. A device as claimed in any preceding claim, wherein the second light source and second receiving means are arranged to monitor the intensity of light of a selected wavelength returning from the retina(s) of the eye(s).
15. A device as claimed in any of claims 1 to 13, wherein the second light source and second receiving means are arranged to monitor the intensity of light of different wavelengths returning from the retina(s) of the eye(s), thereby enabling an absorbance/reflectance characteristic of the retina(s) to be determined.
16. A device substantially as hereinbefore described with reference to, and/or as illustrated by, the accompanying drawings.
US10/468,279 2001-03-09 2002-03-08 Non-invasive spectrophotometer Expired - Fee Related US7853315B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0105784.3 2001-03-09
GB0105784A GB2373044B (en) 2001-03-09 2001-03-09 Non-invasive spectrophotometer
PCT/GB2002/001083 WO2002071932A1 (en) 2001-03-09 2002-03-08 Non-invasive spectrophotometer

Publications (2)

Publication Number Publication Date
US20040133093A1 true US20040133093A1 (en) 2004-07-08
US7853315B2 US7853315B2 (en) 2010-12-14

Family

ID=9910279

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/468,279 Expired - Fee Related US7853315B2 (en) 2001-03-09 2002-03-08 Non-invasive spectrophotometer

Country Status (8)

Country Link
US (1) US7853315B2 (en)
EP (1) EP1365680B1 (en)
JP (1) JP2004525694A (en)
AT (1) ATE378002T1 (en)
CA (1) CA2435987A1 (en)
DE (1) DE60223503T2 (en)
GB (1) GB2373044B (en)
WO (1) WO2002071932A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040087843A1 (en) * 2002-08-26 2004-05-06 Rice Mark J. Non-invasive psychophysical measurement of glucose using photodynamics
US20040147820A1 (en) * 2001-09-13 2004-07-29 Fovioptics, Inc. Non-invasive measurement of blood analytes using photodynamics
US20050010091A1 (en) * 2003-06-10 2005-01-13 Woods Joe W. Non-invasive measurement of blood glucose using retinal imaging
US9442065B2 (en) 2014-09-29 2016-09-13 Zyomed Corp. Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7233817B2 (en) 2002-11-01 2007-06-19 Brian Yen Apparatus and method for pattern delivery of radiation and biological characteristic analysis
JP4236950B2 (en) 2003-02-13 2009-03-11 シスメックス株式会社 Non-invasive living body measurement device
WO2004071287A1 (en) * 2003-02-14 2004-08-26 Novartis Ag Apparatus for measuring an analyte concentration from an ocular fluid
AU2005292074A1 (en) * 2004-09-29 2006-04-13 Materials Research Services IR spectrographic apparatus and method for diagnosis of disease
GB2422660C (en) * 2005-01-27 2018-04-25 H Icheck Ltd Improved device for monitoring body functions
WO2009122114A1 (en) 2008-03-31 2009-10-08 H-Icheck Limited Apparatus for monitoring a human or animal subject's bodily function
US7896498B2 (en) 2009-03-30 2011-03-01 Ottawa Hospital Research Institute Apparatus and method for optical measurements
SG177763A1 (en) 2009-07-28 2012-03-29 Hoffmann La Roche Non-invasive in vivo optical imaging method
GB201000973D0 (en) 2010-01-21 2010-03-10 Glynn Chris Non-evasive spectrophotometer and related method

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157708A (en) * 1975-10-29 1979-06-12 Minolta Camera Kabushiki Kaisha Eye fundus plethysmograph assembly
US4402325A (en) * 1979-09-29 1983-09-06 Minolta Camera Kabushiki Kaisha Ophthalmic device to diagnose the eye fundus
US4533221A (en) * 1983-01-25 1985-08-06 Trachtman Joseph N Methods and apparatus for accommodation training
US4660945A (en) * 1983-01-25 1987-04-28 Trachtman Joseph N Methods and apparatus for accommodation training
US5016643A (en) * 1990-05-02 1991-05-21 Board Of Regents, The University Of Texas System Vascular entoptoscope
US5210554A (en) * 1989-12-11 1993-05-11 Pulse Medical Instruments Pupil pathway analyzer
US5231430A (en) * 1990-07-31 1993-07-27 Canon Kabushiki Kaisha Ophthalmic apparatus
US5297554A (en) * 1989-04-26 1994-03-29 Glynn Christopher J Device for use in real-time monitoring of human or animal bodily function
US5553617A (en) * 1995-01-20 1996-09-10 Hughes Aircraft Company Noninvasive method and apparatus for determining body chemistry
US5632282A (en) * 1993-07-20 1997-05-27 Hay; S. Hutson Ocular disease detection apparatus
US5784145A (en) * 1992-09-28 1998-07-21 St. George's Enterprises Ltd. Apparatus for determining pupil dimensions
US5919132A (en) * 1998-03-26 1999-07-06 Universite De Montreal On-line and real-time spectroreflectometry measurement of oxygenation in a patient's eye
US6231188B1 (en) * 1998-09-22 2001-05-15 Feng Gao Interactive eyewear selection system
US20020091321A1 (en) * 2000-08-21 2002-07-11 Goldstein Lee E. Methods for diagnosing a neurodegenerative condition
US20020151774A1 (en) * 2001-03-01 2002-10-17 Umass/Worcester Ocular spectrometer and probe method for non-invasive spectral measurement
US6494576B1 (en) * 1999-09-30 2002-12-17 L'esperance, Jr. Francis A. Method and apparatus for spectrophotometry of the eye
US6574432B2 (en) * 2000-03-22 2003-06-03 Nidek Co., Ltd. Fundus camera
US6853854B1 (en) * 1998-09-18 2005-02-08 Q Step Technologies, Llc Noninvasive measurement system
US20060200013A1 (en) * 2001-10-22 2006-09-07 Smith John L Systems and methods for maintaining optical fixation and alignment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122961A3 (en) * 1982-10-12 1986-02-19 Optische Werke G. Rodenstock Ocular fundus analyzer
US5433197A (en) * 1992-09-04 1995-07-18 Stark; Edward W. Non-invasive glucose measurement method and apparatus
US5568208A (en) * 1994-03-08 1996-10-22 Van De Velde; Frans J. Modified scanning laser opthalmoscope for psychophysical applications
IL132123A0 (en) * 1997-04-01 2001-03-19 Univ Johns Hopkins A system for imaging an ocular fundus semi-automatically at high resolution and wide field

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157708A (en) * 1975-10-29 1979-06-12 Minolta Camera Kabushiki Kaisha Eye fundus plethysmograph assembly
US4402325A (en) * 1979-09-29 1983-09-06 Minolta Camera Kabushiki Kaisha Ophthalmic device to diagnose the eye fundus
US4533221A (en) * 1983-01-25 1985-08-06 Trachtman Joseph N Methods and apparatus for accommodation training
US4660945A (en) * 1983-01-25 1987-04-28 Trachtman Joseph N Methods and apparatus for accommodation training
US5002384A (en) * 1983-01-25 1991-03-26 Trachtman Joseph N Methods and apparatus for monitoring and training eye position
US5297554A (en) * 1989-04-26 1994-03-29 Glynn Christopher J Device for use in real-time monitoring of human or animal bodily function
US5210554A (en) * 1989-12-11 1993-05-11 Pulse Medical Instruments Pupil pathway analyzer
US5016643A (en) * 1990-05-02 1991-05-21 Board Of Regents, The University Of Texas System Vascular entoptoscope
US5360010A (en) * 1990-05-02 1994-11-01 Board Of Regents, The University Of Texas System Vascular entoptoscope
US5231430A (en) * 1990-07-31 1993-07-27 Canon Kabushiki Kaisha Ophthalmic apparatus
US5784145A (en) * 1992-09-28 1998-07-21 St. George's Enterprises Ltd. Apparatus for determining pupil dimensions
US5632282A (en) * 1993-07-20 1997-05-27 Hay; S. Hutson Ocular disease detection apparatus
US5553617A (en) * 1995-01-20 1996-09-10 Hughes Aircraft Company Noninvasive method and apparatus for determining body chemistry
US5919132A (en) * 1998-03-26 1999-07-06 Universite De Montreal On-line and real-time spectroreflectometry measurement of oxygenation in a patient's eye
US6853854B1 (en) * 1998-09-18 2005-02-08 Q Step Technologies, Llc Noninvasive measurement system
US6231188B1 (en) * 1998-09-22 2001-05-15 Feng Gao Interactive eyewear selection system
US6494576B1 (en) * 1999-09-30 2002-12-17 L'esperance, Jr. Francis A. Method and apparatus for spectrophotometry of the eye
US6574432B2 (en) * 2000-03-22 2003-06-03 Nidek Co., Ltd. Fundus camera
US20020091321A1 (en) * 2000-08-21 2002-07-11 Goldstein Lee E. Methods for diagnosing a neurodegenerative condition
US20020151774A1 (en) * 2001-03-01 2002-10-17 Umass/Worcester Ocular spectrometer and probe method for non-invasive spectral measurement
US20060200013A1 (en) * 2001-10-22 2006-09-07 Smith John L Systems and methods for maintaining optical fixation and alignment

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040147820A1 (en) * 2001-09-13 2004-07-29 Fovioptics, Inc. Non-invasive measurement of blood analytes using photodynamics
US20040087843A1 (en) * 2002-08-26 2004-05-06 Rice Mark J. Non-invasive psychophysical measurement of glucose using photodynamics
US20050010091A1 (en) * 2003-06-10 2005-01-13 Woods Joe W. Non-invasive measurement of blood glucose using retinal imaging
US9442065B2 (en) 2014-09-29 2016-09-13 Zyomed Corp. Systems and methods for synthesis of zyotons for use in collision computing for noninvasive blood glucose and other measurements
US9448165B2 (en) 2014-09-29 2016-09-20 Zyomed Corp. Systems and methods for control of illumination or radiation collection for blood glucose and other analyte detection and measurement using collision computing
US9448164B2 (en) 2014-09-29 2016-09-20 Zyomed Corp. Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
US9453794B2 (en) 2014-09-29 2016-09-27 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
US9459201B2 (en) 2014-09-29 2016-10-04 Zyomed Corp. Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
US9459203B2 (en) 2014-09-29 2016-10-04 Zyomed, Corp. Systems and methods for generating and using projector curve sets for universal calibration for noninvasive blood glucose and other measurements
US9459202B2 (en) 2014-09-29 2016-10-04 Zyomed Corp. Systems and methods for collision computing for detection and noninvasive measurement of blood glucose and other substances and events
US9610018B2 (en) 2014-09-29 2017-04-04 Zyomed Corp. Systems and methods for measurement of heart rate and other heart-related characteristics from photoplethysmographic (PPG) signals using collision computing
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Also Published As

Publication number Publication date
US7853315B2 (en) 2010-12-14
GB2373044A (en) 2002-09-11
GB0105784D0 (en) 2001-04-25
DE60223503T2 (en) 2008-10-23
DE60223503D1 (en) 2007-12-27
EP1365680A1 (en) 2003-12-03
GB2373044B (en) 2005-03-23
EP1365680B1 (en) 2007-11-14
WO2002071932A1 (en) 2002-09-19
CA2435987A1 (en) 2002-09-19
JP2004525694A (en) 2004-08-26
ATE378002T1 (en) 2007-11-15

Similar Documents

Publication Publication Date Title
US7654671B2 (en) Device for monitoring body functions
TWI530272B (en) Apparatus and method for non-invasively detecting diseases that affect structural properties in biological tissues
EP0686372B1 (en) Device for monitoring body functions
US7853315B2 (en) Non-invasive spectrophotometer
EP2525705B1 (en) Non-invasive spectrophotometer and related method
US20020151774A1 (en) Ocular spectrometer and probe method for non-invasive spectral measurement
US5919132A (en) On-line and real-time spectroreflectometry measurement of oxygenation in a patient's eye
US20230064792A1 (en) Illumination of an eye fundus using non-scanning coherent light
AU2002238743A1 (en) Non-invasive spectrophotometer
GB2265003A (en) Real-time monitoring of human bodily functions using optical measurements of the eye

Legal Events

Date Code Title Description
AS Assignment

Owner name: H-ICHECK LTD., CHANNEL ISLANDS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GLYNN, CHRISTOPHER;REEL/FRAME:016499/0255

Effective date: 20050204

AS Assignment

Owner name: GLYNN, CHRISTOPHER, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:H-ICHECK LIMITED;REEL/FRAME:022724/0879

Effective date: 20090216

Owner name: GLYNN, CHRISTOPHER,UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:H-ICHECK LIMITED;REEL/FRAME:022724/0879

Effective date: 20090216

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20141214